Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
24,286
Total Claims
$648K
Drug Cost
311
Beneficiaries
$2,083
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-90%
Opioid rate vs peers
0.3% vs 2.6% avg
+95%
Cost per patient vs peers
$2,083 vs $1,068 avg
+43%
Brand preference vs peers
12.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.3%
Opioid Rate
62
Opioid Claims
$4,321
Opioid Cost
17.7%
Long-Acting Rate
Brand vs Generic
Brand: 3,120 claims · $411K
Generic: 21,086 claims · $232K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 947 | $138K |
| Rivaroxaban | 205 | $28K |
| Sitagliptin Phosphate | 180 | $25K |
| Mirabegron | 181 | $21K |
| Insulin Aspart | 49 | $20K |
| Insulin Aspart | 53 | $16K |
| Clomipramine Hcl | 45 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 36 | $11K |
| Empagliflozin | 46 | $11K |
| Linagliptin | 77 | $10K |
| Insulin Glargine,hum.Rec.Anlog | 55 | $9,580 |
| Atorvastatin Calcium | 1,425 | $9,438 |
| Potassium Chloride | 910 | $9,102 |
| Pantoprazole Sodium | 1,054 | $7,924 |
| Insulin Glargine,hum.Rec.Anlog | 60 | $7,636 |
Prescribing Profile
Patient Profile
80
Avg Age
64%
Female
2.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About